1.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: C-100-12 Part I, NCT00033904
|
|
2.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: C-100-21, NCT00039000
|
|
3.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: 05103, P30CA082103, UCSF-05103, UCSF-H41995-27311-01, NCT00293423
|
|
4.
|
Phase: Phase II Type: Treatment Status: Completed Age: Over 18 Sponsor: NCI Protocol IDs: MSKCC-99077, NCI-H00-0052, NCT00005628
|
|
5.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: C-100-26, NCT00098085
|
|
6.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: MSKCC-97034, ANTIGENICS-C-100-01, NCI-G97-1271, NCT00003025
|